Clincosm LogoSign in Get a demo

Leukemia, Lymphoid

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

Recruiting
  • Leukemia, Lymphoid
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Oct 27, 2023

Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

Not yet recruiting
  • Leukemia, Lymphoid
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Oct 3, 2023

Immune Reconstitution After Allo-HSCT and Blinatumomab

Not yet recruiting
  • Leukemia, Lymphoid
  • (no location specified)
Oct 3, 2023

Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell Trial in China (LOXO-305)

Active, not recruiting
  • Leukemia, Lymphoid
  • +6 more
  • Wuhu, Anhui, China
  • +22 more
Dec 8, 2022

Analyses of Human Samples Collected in Clinical Trials

Completed
  • Leukemia, Myeloid
  • +3 more
    • Washington, District of Columbia
    • +16 more
    Mar 27, 2020

    Leukemia, Lymphoid, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Trial in France (Lenalidomide plus dexamethasone)

    Completed
    • Leukemia, Lymphoid
    • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
    • Lenalidomide plus dexamethasone
    • Clermont-Ferrand, France
    • +3 more
    Sep 13, 2017

    Leukemia, Myeloid, Acute, Leukemia, Lymphoid, MDS Trial in Indianapolis (CliniMACS CD34 Reagent System)

    Terminated
    • Leukemia, Myeloid, Acute
    • +3 more
    • CliniMACS CD34 Reagent System
    • Indianapolis, Indiana
      Indiana University Cancer Center
    Aug 28, 2015